Watchtower Advisors’s AdaptHealth AHCO Stock Holding History

Watchtower Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-297,607	Closed	-$5.59M	–	15
2022 Q3	$5.59M	Buy	+297,607	New	+$6.12M	4.34%	7

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Watchtower Advisors's AHCO Position: Q4 2022 in Review

Watchtower Advisors sold out of AdaptHealth (AHCO) in Q4 2022, closing a stake of 297,607 shares — an estimated $5.59M sold.

Watchtower Advisors first reported a position in AHCO in Q3 2022 and held it in 1 quarter. The position peaked at $5.59M in Q3 2022. 193 funds tracked by Wall St. Rank hold AHCO as of Q4 2022.

Watchtower Advisors reported no remaining AdaptHealth position as of Q4 2022 after selling out during the quarter.
Watchtower Advisors sold 297,607 AdaptHealth shares in Q4 2022, an estimated $5.59M.
Watchtower Advisors first reported a position in AdaptHealth in Q3 2022 and held it in 1 quarter.
Watchtower Advisors's AdaptHealth position peaked at $5.59M in Q3 2022.
193 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2022.

Based on Watchtower Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.